Evidence map›Paper›PMID 24918016›Full record

ArticleUnited European gastroenterology journal2014

Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?

Franco Scaldaferri, Loris Riccardo Lopetuso, Valentina Petito, Valerio Cufino, Mirna Bilotta, Vincenzo Arena, Egidio Stigliano, Giuseppe Maulucci, Massimiliano Papi, Caristo Maria Emiliana and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in United European gastroenterology journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Evaluation of Gelatin Tannate Against Symptoms of Acute Diarrhea in Pediatric Patients.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Trial
  2. Trial
  3. Article
  4. Gelatin tannate in pediatric infectious gastroenteritis.Translational gastroenterology and hepatology · 2026
    Review
  5. IgA class-switched CD27-CD21+ B cells in IgA nephropathy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. The Gut Microbiota: A Novel Player in Autoimmune Hepatitis.Frontiers in cellular and infection microbiology · 2022
    Review
  10. Article
  11. Article
  12. Insects · 2021
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Engineering the Mucus Barrier.Annual review of biomedical engineering · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Franco ScaldaferriInternal Medicine, Gastroenterology Division, Catholic University of the Sacred Heart, Rome, Italy.
Loris Riccardo LopetusoInternal Medicine, Gastroenterology Division, Catholic University of the Sacred Heart, Rome, Italy.
Valentina PetitoInternal Medicine, Gastroenterology Division, Catholic University of the Sacred Heart, Rome, Italy.
Valerio CufinoPathology Department, Catholic University of the Sacred Heart, Rome, Italy.
Mirna BilottaMicrobiology Department, Catholic University of the Sacred Heart, Rome, Italy.
Vincenzo ArenaPathology Department, Catholic University of the Sacred Heart, Rome, Italy.
Egidio StiglianoPathology Department, Catholic University of the Sacred Heart, Rome, Italy.
Giuseppe MaulucciPhysics Department, Catholic University of the Sacred Heart, Rome, Italy.
Massimiliano PapiPhysics Department, Catholic University of the Sacred Heart, Rome, Italy.
Caristo Maria EmilianaCentro di Ricerche Sperimentali, Catholic University of the Sacred Heart, Rome, Italy.
Andrea PosciaInstitute of Hygiene, Catholic University of the Sacred Heart, Rome, Italy.
Francesco FranceschiInternal Medicine, Gastroenterology Division, Catholic University of the Sacred Heart, Rome, Italy.
Giovanni DeloguMicrobiology Department, Catholic University of the Sacred Heart, Rome, Italy.
Maurizio SanguinettiMicrobiology Department, Catholic University of the Sacred Heart, Rome, Italy.
Marco De SpiritoPhysics Department, Catholic University of the Sacred Heart, Rome, Italy.
Alessandro SgambatoPathology Department, Catholic University of the Sacred Heart, Rome, Italy.
Antonio GasbarriniInternal Medicine, Gastroenterology Division, Catholic University of the Sacred Heart, Rome, Italy.
Università Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGelatin tannate, a gelatin powder containing tannic acids, is commonly employed as an intestinal astringent. Neither information nor animal model exist to confirm its efficacy or unravel mechanisms of action.

objectiveTo evaluate the action of gelatin tannate in murine dextran sodium sulphate (DSS)-induced acute colitis.

methodsMice were exposed to DSS and received gelatin tannate by gavage. At sacrifice, colon histological degree of inflammation was assessed. Stool samples were cultured for microbiological analysis. Colon samples were analysed by two-photon confocal microscopy and atomic force microscopy. Elisa was performed on murine serum to assess lipopolysaccharide and peptidoglycan levels.

resultsGelatin tannate treatment reduced disease activity, bodyweight loss, and preserved colonic length. It produced a decrease in the amount of enterobacteria and enterococci. At confocal microscopy, intestinal samples from healthy and treated mice displayed similar structure in mucus layer thickness and composition; samples from placebo group had no mucus layer or a thinner stratus. Atomic force microscopy confirmed these findings. Treated mice showed lower blood LPS levels vs. control.

conclusionsGelatin tannate decreased the severity of colitis. Acting as a gut barrier enhancer, it re-establishes gut homeostasis by recovering intestinal permeability and mucus layer integrity in gut mucosa and by modulating microbiota composition.

Indexed as

DSS-acute colitisgelatin tannategut barriergut microbiotaintestinal mucus

Identifiers

PMID24918016
PMCPMC4040816
OpenAlexW2169300857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.